metastatic breast cancer
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
metastatic breast cancer
Jul 10, 2024, 17:46 |
Blog
Gary L. Thompson: Lesley Fallowfield exploring ways to enable clinicians and genetic counselors to discuss challenging topics
Gary L. Thompson, Board Chair of Side-Out Foundation, shared on X: “Day 208/262 of my…
Jul 8, 2024, 18:14 |
Insight
Paolo Tarantino: What is HER2 « ultralow » breast cancer, and why should you care?
Paolo Tarantino shared on X: “What is HER2 « ultralow » breast cancer, and why…
Jul 8, 2024, 15:07 |
Blog
To say that we are heartbroken about losing our dear Marlena Murphy is an understatement - PIK3CA Path Breakers
PIK3CA Path Breakers shared on X: “To say that we are heartbroken about losing our…
Jul 8, 2024, 12:44 |
Insight
Tatiana Prowell: Another person with Metastatic Breast Cancer taken too soon
Tatiana Prowell shared a post on X: “I am so grateful that I had the…
Jun 26, 2024, 03:18 |
Insight
Paolo Tarantino: The 5 S rules help memorizing a simple framework to manage ILD
Paolo Tarantino shared on LinkedIn: “T-DXd is rapidly expanding in indications, from HER2+, to HER2-low, and…
Jun 25, 2024, 16:01 |
Insight
Paolo Tarantino: Phase 1 trial of the HER2 topo1 ADC SHR-A1811 out in Journal of Clinical Oncology
Paolo Tarantino shared on X: . "Phase 1 trial of the HER2 topo1 ADC SHR-A1811…
Jun 19, 2024, 12:33 |
Blog
Maria Babak: How Bevacizumab is revolutionizing treatment for multiple cancers
Maria Babak shared a post by CityU iGEM on LinkedIn: "Discover how Bevacizumab, a powerful cancer…
Jun 15, 2024, 04:53 |
Insight
Felipe Rodrigues: Excited to share our work on the reciprocal interaction between metastatic cancer cells and AT2 cells
Felipe Rodrigues, Postdoctoral Researcher at Rockefeller University, recently shared a post on X: "Beyond excited…
Jun 14, 2024, 21:00 |
Blog
Michail Ignatiadis: Humble to have led this EBCC14 manifesto
Quoting Michail Ignatiadis, Director of Breast Medical Oncology Clinic and Program, Jules Bordet Institute, on…
Jun 10, 2024, 16:25 |
Blog
Vicki Durston: Thrilled to announce the launch of our new Metastatic Breast Cancer Media Guide
Vicki Durston, President of the General Assembly and Board Member at ABC Global Alliance, shared…
Jun 10, 2024, 07:18 |
Blog
Francisco J. Esteva: Emerging technologies are set to revolutionize the detection and application of biomarkers in cancer treatment
Francisco J. Esteva, Chief of the Division of Hematology and Medical Oncology at Lenox Hill…
Jun 6, 2024, 00:29 |
Blog
Paolo Tarantino: Expansion cohorts from TBCRC by Nadine Tung
Paolo Tarantino shared a post on X: “One of the most important presentations of ASCO24:…
Jun 5, 2024, 15:22 |
Insight
Piotr Wysocki: T-DXd in metastatic ER+/HER2-low breast cancer patients after endocrine treatment failure
Piotr Wysocki recently posted on LinkedIn: "Results of a Destiny-Breast06 trial have been presented by…
May 31, 2024, 15:41 |
Societies
Paolo Tarantino: More than 25 ASCO24 oral presentations by Dana-Farber Cancer Institute researchers
Paolo Tarantino shared a post by Dana-Farber Cancer Institute on X: "More than 25 ASCO24…
May 27, 2024, 04:24 |
Blog
Nazik Hammad: An honour to be part of the 2024 Best Health for Black Women virtual event
Nazik Hammad shared a post by Women's College Hospital, on LinkedIn: "Canadian Black women getting together…
May 24, 2024, 00:58 |
Blog
Francisco J. Esteva on the DESTINY-Breast06 trial
Francisco J. Esteva, Chief of Division of Hematology and Medical Oncology at Lenox Hill Hospital, shared…
May 23, 2024, 12:46 |
Blog
ESMO - This novel combination therapy holds great promise for BRCA-mutated metastatic Breast Cancers
ESMO shared a post on LinkedIn: "ESMOBreast24: phase 2 data on combining olaparib, durvalumab, and fulvestrant…
May 23, 2024, 11:18 |
Insight
Top 5 articles of the week in Cancer Network
Cancer Network shared on X: "View the top 5 articles of the week: FDA Approves…
May 22, 2024, 13:20 |
Blog
Adam MacLean: A new Neu - a syngeneic model of spontaneously metastatic HER2‑positive breast cancer
Adam MacLean, Assistant Professor at University of Southern California, made the following post on X:…
May 18, 2024, 01:30 |
Blog
Eva Schumacher-Wulf: Best poster prize at ESMOBreast24!
Eva Schumacher-Wulf, Editor-in-Chief of Mamma Mia! Magazine, shared on X: "More than proud about the…
May 13, 2024, 09:09 |
Blog
Sarah Sammons: Join us for dinner and lively discussion on novel therapies for HR+ MBC
Sarah Sammons shared on X: "Join Aditya Bardia, Virginia Kaklamani and I 6/1 for dinner…
May 8, 2024, 23:17 |
Insight
Giampaolo Bianchini: Join us at the next ESMO Virtual Plenary session!
Elisa Agostinetto, Research Physician at Institute of Jules Bordet in Brussels, shared a post by Giampaolo…
May 7, 2024, 06:17 |
Opinion
Roberta Lombardi: This is what is wrong with our system
Roberta Lombardi, Founder of Infinite Strength, shared on X: "This is an example of reality…
May 4, 2024, 10:27 |
Insight
Paolo Tarantino: HER2 is about to change again
Paolo Tarantino shared a previous post of him on X and added: "HER2 is about…
May 2, 2024, 15:20 |
Blog
Paolo Tarantino: Impressive to think at the journey of ADCs over the last five years
Paolo Tarantino shared on LinkedIn: "Impressive to think at the journey of ADCs over the last…
May 2, 2024, 01:09 |
Blog
Wendy Woodward: MBC Impact Series - Inflammatory Breast Cancer
Wendy Woodward, Radiation Oncology Inflammatory Breast Cancer Specialist and Scientist at MD Anderson Cancer Center, shared…
Apr 29, 2024, 15:54 |
Insight
Toni Choueiri: Big news to start the day: DESTINY-Breast06 Phase III trial
Toni Choueiri shared on X: "Big news to start the day: DESTINY-Breast06 Phase III trial…
Apr 29, 2024, 07:15 |
Blog
Maryam Lustberg: Thank you Roberta Lombardi for fundraising for patients with metastatic breast cancer
Maryam Lustberg shared a post on X/Twitter by Infinite Strength adding: "Thank you Roberta Lombardi…
Apr 27, 2024, 11:08 |
Blog
Christine Desmedt: Proud to present our post-mortem tissue donation program UPTIDER
Christine Desmedt, Assistant Professor at the Katholieke University Leuven, shared on X/Twitter: "Proud to present our…
Apr 26, 2024, 15:30 |
Blog
Tatiana Prowell: We just lost one of the greats Sheila Johnson
Tatiana Prowell shared on X/Twitter: ''We just lost one of the greats, Sheila Johnson. A…
Apr 24, 2024, 12:58 |
Positive
Runcie C.W. Chidebe: I am so excited that my study won the Dr. Jerome Kaplan Outstanding Graduate Paper at the 2024 Ohio Association of Gerontology and Education (OAGE) Conference
Apr 23, 2024, 17:04 |
Blog
Julia Maués: Who didn't have that thought cross their mind when diagnosed with cancer?
Julia Maués, Co-Founder of Grasp Cancer, shared a post on X/Twitter: "'What if I do…
Apr 22, 2024, 10:46 |
Blog
Everyone at Susan G. Komen is devastated to learn that Sheila Johnson passed away from metastatic breast cancer
Susan G. Komen shared on LinkedIn: "Everyone at Susan G. Komen is devastated to learn that…
Apr 20, 2024, 06:51 |
Drugs
Joosje Baltussen: Our article studying tolerability and effectiveness of Palbociclib in older women with metastatic breast cancer
Joosje Baltussen, Chair of Young SIOG (International Society of Geriatric Oncology) shared on X: “Just…
Apr 18, 2024, 14:48 |
Insight
Billy Rosa: An honor to serve on the writing committee for The Lancet Breast Cancer Commission led by the incredible Charlotte Coles
Billy Rosa, Assistant Attending Behavioral Scientist at MSK Cancer Center, shared a post by The Lancet…
Apr 13, 2024, 07:26 |
Blog
Massimo Cristofanilli: Development of endocrine resistance can be associated with loss of ER expression in CTCs
Massimo Cristofanilli, Professor of Medicine and Director of Breast Medical Oncology, Division of Hematology/Oncology at Weill…
Apr 6, 2024, 10:04 |
Drugs
Jean Zeghondy: Our work on Tucatinib combination post Trastuzumab-Deruxtecan in HER2+ Metastatic Breast Cancer published in JAMA Network Open
Jean Zeghondy, Associate Practitioner at the Breast Cancer Unit at Gustave Roussy, shared a post…
Apr 1, 2024, 00:34 |
Insight
Sami Mansfield: New Insights on Exercise & Metastatic Breast Cancer
Sami Mansfield, Founder of Cancer Wellness for Life, shared on LinkedIn: “New Insights on Exercise &…
Mar 26, 2024, 04:50 |
Insight
The latest ASCO podcast on the rapid guideline update on endocrine and targeted therapy for HR+, HER2+ metastatic breast cancer - Dana-Farber's Breast Oncology Center
Dana-Farber's Breast Oncology Center shared on X/Twitter: "Listen to the latest ASCO podcast where Dr.…
Mar 23, 2024, 23:01 |
Blog
Maryam Lustberg: In honor of PCDI’s founder Anne Loeser this piece stands as a heartfelt tribute to her legacy following her passing on October 10, 2023 from metastatic breast cancer
Mar 14, 2024, 19:28 |
Drugs
François-Clément Bidard: A prospective study to document the efficacy of the combo Fulvestrant+Everolimus
Erika Hamilton, Director of Breast Cancer and Gynecologic Cancer Research at Sarah Cannon Research Institute, shared…
Mar 8, 2024, 19:03 |
Insight
Lea Monteran: TIGIT blockade with MDSC inhibition may be a novel and promising therapeutic strategy to treat bone metastasis
Lea Monteran, Ph.D. student at Tel Aviv University, shared on X/Twitter: "I am excited to…
Mar 7, 2024, 17:47 |
Blog
Janice Cowden: As people diagnosed with metastatic breast cancer, we have a lot to say about dose optimization and treatment-related side effects
Janice Cowden shared a post on LinkedIn: "As people diagnosed with metastatic breast cancer, we…
Feb 28, 2024, 18:52 |
Blog
Sana Sukhun: ASCO Releases Resource-Stratified Guideline for the Treatment of Metastatic Breast Cancer
Sana Sukhun, President of the Jordanian Society of American Medical Graduates, shared a post on X/Twitter:…
Feb 19, 2024, 18:30 |
Insight
Erman Akkus: Advanced breast cancer in 2023
Erman Akkus, Medical Oncology Fellow at Ankara University, shared on X/Twitter: "Best of the year:…
Feb 14, 2024, 18:56 |
Blog
Melanie Sisk: We are looking for volunteers who want to make a tangible impact in the lives of patients whose cancer has the PIK3CA mutation
Melanie Sisk, Metastatic Breast Cancer Patient Advocate, shared on X/Twitter: "Hello PIK3CA members. We are looking…
Jan 13, 2024, 12:58 |
Blog
Sana Al Sukhun: Delighted to have chaired a wonderful committee to bring forward support for colleagues treating breast cancer
Sana Al Sukhun, Co-Chair of RSG Committee of ASCO for Metastatic Breast Cancer, shared on…
Dec 17, 2023, 23:13 |
Blog
Margaret Gatti-Mays: Still Haven’t Found What We’re Looking For
Margaret Gatti-Mays, Associate Professor in the Division of Medical Oncology at the OSUCCC – James…
Dec 13, 2023, 16:29 |
Insight
Aruni Ghose: With Bhawna Sirohi, Miriam Mutebi and Sarah Adomah I was priviledged to lead this piece on Advanced Breast Cancer Care
Aruni Ghose, Council member at Royal Society of Medicine, shared on LinkedIn: "Celia Diez de…
Dec 5, 2023, 12:53 |
Insight
Vicki Durston: We were very proud to announce and launch our final report Time to Count People with Metastatic Breast Cancer
Vicki Durston, Director of Policy and Advocacy at Breast Cancer Network Australia, shared on LinkedIn:…
Nov 6, 2023, 04:03 |
Blog
Paolo Tarantino: Make sure not to miss our presentation of RELIEVE at the San Antonio Breast Cancer Symposium (SABCS23)
Paolo Tarantino, Research Fellow at the Dana-Farber Cancer Institute, shared on X/Twitter: "Trastuzumab Deruxtecan (T-DXd)…
Oct 31, 2023, 16:04 |
Positive
Our goal has always been to make a real difference in the lives of single mothers with MBC - Infinite Strength
According to a tweet from the Twitter account Infinite Strength: ''We have found that 6…
Oct 21, 2023, 23:44 |
Blog
Janice Cowden: We marched on Capitol Hill with Metavivor Research and Support Inc. to advocate for increased funding for Metastatic Breast Cancer
Janice Cowden, Metastatic Breast Cancer Patient Advocate, made the following post on LinkedIn "This week…
Oct 12, 2023, 01:34 |
Opinion
Alexander Hardy: Today, we're commemorating a significant milestone at Genentech - the 25th anniversary of a groundbreaking medicine for patients with HER2+ metastatic breast cancer.
Aug 31, 2023, 19:05 |
Blog
Sandy Cassanelli: Looking forward to this fabulous event for Metastatic Breast Cancer patients.
Sandy Cassanelli, the CEO of Greenough Packaging and Maintenance Supplies and Breast Friends Fund-Funding Research…
Aug 15, 2023, 09:15 |
Insight
Paolo Tarantino: Delivering chemo via HER2- and Trop2-targeted Antibody-drug conjugates (ADCs) has reshaped the way we treat Metastatic breast cancer (MBC)
Paolo Tarantino, MD, Clinical Research Fellow at Dana-Farber Cancer Institute, stated on Twitter: "Delivering chemo…
Jul 2, 2023, 09:44 |
Societies
Conquer Cancer, the ASCO Foundation announced the recipients of pfizer grand
We’re proud to announce the recipients pfizer grants totaling over $1M for researchers working to…
All:
57
Posts:
1 - 100
The largest philanthropic partnership in The V Foundation’s history - Dolphins Cancer Challenge
Glecirasib: A Promising Novel KRAS G12C Inhibitor in Clinical Development
How the Médecins Sans Frontières Journal Inspired a Lifetime of Humanitarian Service: Paul Spiegel
OncoDaily Party and Yvonne Award Photos - Part 1
Michael Douglas: The Untold Story of His Battle Against Cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube